Medifast (MED) EBT (2010 - 2026)

Medifast has reported EBT for 17 years, with the latest figure at -$1.9 million in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 469.01% year-over-year to -$1.9 million; the trailing twelve-month figure through Mar 2026 stood at -$8.1 million (down 11.47% YoY), and the FY2025 full-year result was -$5.6 million, down 248.9% from the prior year.
• EBT for Q1 2026 stood at -$1.9 million, up from -$6.4 million in the prior quarter.
• The five-year high for EBT was $55.0 million in Q1 2022, with the low at -$10.6 million in Q2 2024.
• Historically, EBT has averaged $18.2 million across 5 years, with a median of $9.8 million in 2023.
• The largest YoY upside for EBT was 127.0% in 2025 against a maximum downside of 600.55% in 2025.
• Medifast's EBT stood at $32.4 million in 2022, then tumbled by 69.75% to $9.8 million in 2023, then plunged by 86.99% to $1.3 million in 2024, then tumbled by 600.55% to -$6.4 million in 2025, then surged by 69.59% to -$1.9 million in 2026.
• The last three EBT figures came in at -$1.9 million (Q1 2026), -$6.4 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.